SCCT 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography: A Report of the Society of Cardiovascular Computed Tomography.
SCCT 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography: A Report of the Society of Cardiovascular Computed Tomography.
复制标题
DOI:
10.1016/j.jcct.2020.11.001
复制
发表时间:
2021-05
影响因子:
5.4
通讯作者:
Hecht HS
中科院分区:
文献类型:
--
作者:
Narula J;Chandrashekhar Y;Ahmadi A;Abbara S;Berman DS;Blankstein R;Leipsic J;Newby D;Nicol ED;Nieman K;Shaw L;Villines TC;Williams M;Hecht HS
Cardiac computed tomography (CT) has changed rapidly since the last major guideline from SCCT. 1 While there have been significant advances in technology, the most gratifying part has been the development of a robust evidence base for the use of cardiac CT in diagnoses of heart disease, prognostication and modulating therapy (both medical and interventional). Such a systematic development of knowledge base has not been the usual practice for any other imaging modality before widespread clinical acceptance in the past. It is no surprise that major guideline bodies have started to endorse incorporation of cardiac CT more definitively than before, and some, like the NICE guidelines in the UK, 2 have even given it first line status. While CTA has been shown to be very good for prognosticating risk, excluding significant coronary artery disease (CAD) in stable patients with chest pain and has high sensitivity for the identification of significant coronary stenoses, it is somewhat less robust in specificity and positive predictive accuracy, leading to the development of value added CT angiography (CTA) strategies like fractional flow reserve derived from CT (CT-FFR) and CT perfusion (CTP); these have arrived into the clinical arena since the last guidelines and, more importantly, have produced a large volume of scientific data showing significant clinical utility. Finally, some questions that often arise in regular clinical practice lack robust trial based evidence and a considered expert opinion might help the clinician make appropriate decisions in everyday practice. It is thus clear that an updated scholarly compendium of recent data is needed to bridge the knowledge gap since the last iteration of the SCCT guideline documents. This SCCT consensus statement summarizes current evidence, updates previous recommendations, addresses key questions regarding the use of CTA in multiple different cardiac scenarios and brings together the collective corpus of literature in the form of definitive recommendations. CTA in acute coronary syndromes will be presented in a separate document. The Expert Consensus recommendations are summarized in Table 1 and Fig. 1.
登录
查看更多内容
影响因子:
4.8
作者:
Andreini, Daniele;Pontone, Gianluca;Pepi, Mauro
通讯作者:
Pepi, Mauro
影响因子:
5.5
作者:
Bilchick KC;Mealor A;Gonzalez J;Norton P;Zhuo D;Mason P;Ferguson JD;Malhotra R;Michael Mangrum J;Darby AE;DiMarco J;Hagspiel K;Dent J;Kramer CM;Stukenborg GJ;Salerno M
通讯作者:
Salerno M
影响因子:
14
作者:
Andreini, Daniele;Mushtaq, Saima;Pepi, Mauro
通讯作者:
Pepi, Mauro
影响因子:
24
作者:
Andreini, Daniele;Pontone, Gianluca;Agostoni, Piergiuseppe
通讯作者:
Agostoni, Piergiuseppe
影响因子:
14
作者:
Bakhshi, Hooman;Meyghani, Zahra;Arbab-Zadeh, Armin
通讯作者:
Arbab-Zadeh, Armin